SI
NUS icon

Standard Investments’s Nu Skin NUS Stock Holding History

Standard Investments’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-51,318
Closed -$4.25M – 191
2014
Q1 		$4.25M Buy
+51,318
New +$4.51M 0.4% 41

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ESG
Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
EPCM
Eton Park Capital Management New York $2.28B AUM 33.59% 1-Year Est. Return

Standard Investments's NUS Position: Q2 2014 in Review

Standard Investments sold out of Nu Skin (NUS) in Q2 2014, closing a stake of 51,318 shares — an estimated $4.25M sold.

Standard Investments first reported a position in NUS in Q1 2014 and held it in 1 quarter. The position peaked at $4.25M in Q1 2014. 267 funds tracked by Wall St. Rank hold NUS as of Q2 2014.

  • Standard Investments reported no remaining Nu Skin position as of Q2 2014 after selling out during the quarter.
  • Standard Investments sold 51,318 Nu Skin shares in Q2 2014, an estimated $4.25M.
  • Standard Investments first reported a position in Nu Skin in Q1 2014 and held it in 1 quarter.
  • Standard Investments's Nu Skin position peaked at $4.25M in Q1 2014.
  • 267 funds tracked by Wall St. Rank held Nu Skin as of Q2 2014.

Based on Standard Investments's 13F filing for Q2 2014, filed 14 Aug 2014.